Subpart 229.700 — Miscellaneous
229.701 — (Item 701) Recent sales of unregistered securities; use of proceeds from registered securities.
Furnish the following information as to all securities of the registrant sold by the registrant within the past three years which were not registered under the Securities Act. Include sales of reacquired securities, as well as new issues, securities issued in exchange for property, services, or other securities, and new securities resulting from the modification of outstanding securities.
(a) Securities sold. Give the date of sale and the title and amount of securities sold.
(b) Underwriters and other purchasers. Give the names of the principal underwriters, if any. As to any such securities not publicly offered, name the persons or identify the class of persons to whom the securities were sold.
(c) Consideration. As to securities sold for cash, state the aggregate offering price and the aggregate underwriting discounts or commissions. As to any securities sold otherwise than for cash, state the nature of the transaction and the nature and aggregate amount of consideration received by the registrant.
(d) Exemption from registration claimed. Indicate the section of the Securities Act or the rule of the Commission under which exemption from registration was claimed and state briefly the facts relied upon to make the exemption available.
(e) Terms of conversion or exercise. If the information called for by this paragraph (e) is being presented on Form 8-K, Form 10-Q, Form 10-K, or Form 10-D under the Exchange Act (§ 249.308, § 249.308(a), § 240.310 or § 249.312) of this chapter, and where the securities sold by the registrant are convertible or exchangeable into equity securities, or are warrants or options representing equity securities, disclose the terms of conversion or exercise of the securities.
(f) Use of proceeds. As required by § 230.463 of this chapter, following the effective date of the first registration statement filed under the Securities Act by an issuer, the issuer or successor issuer shall report the use of proceeds on its first periodic report filed pursuant to sections 13(a) and 15(d) of the Exchange Act (15 U.S.C. 78m(a) and 78o(d)) after effectiveness of its Securities Act registration statement, and thereafter on each of its subsequent periodic reports filed pursuant to sections 13(a) and 15(d) of the Exchange Act through the later of disclosure of the application of all the offering proceeds, or disclosure of the termination of the offering. If a report of the use of proceeds is required with respect to the first effective registration statement of the predecessor issuer, the successor issuer shall provide such a report. The information provided pursuant to paragraphs (f)(2) through (f)(4) of this Item need only be provided with respect to the first periodic report filed pursuant to sections 13(a) and 15(d) of the Exchange Act after effectiveness of the registration statement filed under the Securities Act. Subsequent periodic reports filed pursuant to sections 13(a) and 15(d) of the Exchange Act need only provide the information required in paragraphs (f)(2) through (f)(4) of this Item if any of such required information has changed since the last periodic report filed. In disclosing the use of proceeds in the first periodic report filed pursuant to the Exchange Act, the issuer or successor issuer should include the following information:
(1) The effective date of the Securities Act registration statement for which the use of proceeds information is being disclosed and the Commission file number assigned to the registration statement;
(2) If the offering has commenced, the offering date, and if the offering has not commenced, an explanation why it has not;
(3) If the offering terminated before any securities were sold, an explanation for such termination; and
(4) If the offering did not terminate before any securities were sold, disclose:
(i) Whether the offering has terminated and, if so, whether it terminated before the sale of all securities registered;
(ii) The name(s) of the managing underwriter(s), if any;
(iii) The title of each class of securities registered and, where a class of convertible securities is being registered, the title of any class of securities into which such securities may be converted;
(iv) For each class of securities (other than a class of securities into which a class of convertible securities registered may be converted without additional payment to the issuer) the following information, provided for both the account of the issuer and the account(s) of any selling security holder(s): the amount registered, the aggregate price of the offering amount registered, the amount sold and the aggregate offering price of the amount sold to date;
(v) From the effective date of the Securities Act registration statement to the ending date of the reporting period, the amount of expenses incurred for the issuer's account in connection with the issuance and distribution of the securities registered for underwriting discounts and commissions, finders' fees, expenses paid to or for underwriters, other expenses and total expenses. Indicate if a reasonable estimate for the amount of expenses incurred is provided instead of the actual amount of expense. Indicate whether such payments were:
(A) Direct or indirect payments to directors, officers, general partners of the issuer or their associates; to persons owning ten (10) percent or more of any class of equity securities of the issuer; and to affiliates of the issuer; or
(B) Direct or indirect payments to others;
(vi) The net offering proceeds to the issuer after deducting the total expenses described in paragraph (f)(4)(v) of this Item;
(vii) From the effective date of the Securities Act registration statement to the ending date of the reporting period, the amount of net offering proceeds to the issuer used for construction of plant, building and facilities; purchase and installation of machinery and equipment; purchases of real estate; acquisition of other business(es); repayment of indebtedness; working capital; temporary investments (which should be specified); and any other purposes for which at least five (5) percent of the issuer's total offering proceeds or $100,000 (whichever is less) has been used (which should be specified). Indicate if a reasonable estimate for the amount of net offering proceeds applied is provided instead of the actual amount of net offering proceeds used. Indicate whether such payments were:
(A) Direct or indirect payments to directors, officers, general partners of the issuer or their associates; to persons owning ten (10) percent or more of any class of equity securities of the issuer; and to affiliates of the issuer; or
(B) Direct or indirect payments to others; and
(viii) If the use of proceeds in paragraph (f)(4)(vii) of this Item represents a material change in the use of proceeds described in the prospectus, the issuer should describe briefly the material change.
Instructions. 1. Information required by this Item 701 need not be set forth as to notes, drafts, bills of exchange, or bankers' acceptances which mature not later than one year from the date of issuance.
2. If the sales were made in a series of transactions, the information may be given by such totals and periods as will reasonably convey the information required.
[47 FR 11401, Mar. 16, 1982, as amended at 61 FR 54508, Oct. 18, 1996; 62 FR 39762, July 24, 1997; 70 FR 1597, Jan. 7, 2005; 73 FR 967, Jan. 4, 2008]
229.702 — (Item 702) Indemnification of directors and officers.
State the general effect of any statute, charter provisions, by-laws, contract or other arrangements under which any controlling persons, director or officer of the registrant is insured or indemnified in any manner against liability which he may incur in his capacity as such.
229.703 — Purchases of equity securities by the issuer and affiliated purchasers.
(a) In the following tabular format, provide the information specified in
paragraph (b) of this Item with respect to any purchase made by or on behalf of the
issuer or any “affiliated purchaser,” as defined in § 240.10b-18(a)(3) of this
chapter of shares or other units of any class of the issuer's equity securities that
is registered by the issuer pursuant to section 12 of the Exchange Act (15 U.S.C. 78
1).
Period
|
(a) Total number of shares (or units)
purchased
|
(b) Average price paid per share (or
unit)
|
(c) Total number of shares (or units)
purchased as part of publicly announced plans or
programs
|
(d) Maximum number (or approximate dollar
value) of shares (or units) that may yet be purchased under
the plans or programs
|
---|---|---|---|---|
Month #1 (identify beginning and ending
dates).
| ||||
Month #2 (identify beginning and ending
dates).
| ||||
Month #3 (identify beginning and ending
dates).
| ||||
Total
|
(b) The table shall include the following information for each class or series of
securities for each month included in the period covered by the report:
(1) The total number of shares (or units) purchased (column (a));
Instruction to paragraph (b)(1) of Item 703: Include in this column all issuer
repurchases, including those made pursuant to publicly announced plans or programs
and those not made pursuant to publicly announced plans or programs. Briefly
disclose, by footnote to the table, the number of shares purchased other than
through a publicly announced plan or program and the nature of the transaction
(e.g., whether the purchases were made in open-market transactions,
tender offers, in satisfaction of the company's obligations upon exercise of
outstanding put options issued by the company, or other transactions).
(2) The average price paid per share (or unit) (column (b));
(3) The total number of shares (or units) purchased as part of publicly announced
repurchase plans or programs (column (c)); and
(4) The maximum number (or approximate dollar value) of shares (or units) that may
yet be purchased under the plans or programs (column (d)).
Instructions to paragraphs (b)(3) and (b)(4) of Item 703:
1. In the table, disclose this information in the aggregate for all plans or programs
publicly announced.
2. By footnote to the table, indicate:
a. The date each plan or program was announced;
b. The dollar amount (or share or unit amount) approved;
c. The expiration date (if any) of each plan or program;
d. Each plan or program that has expired during the period covered by the table;
and
e. Each plan or program the issuer has determined to terminate prior to expiration,
or under which the issuer does not intend to make further purchases.
Instruction to Item 703: Disclose all purchases covered by this Item,
including purchases that do not satisfy the conditions of the safe harbor of
§ 240.10b-18 of this chapter.
[68 FR 64969, Nov. 17, 2003; as amended at 88 FR 36002, June 1, 2023; 89 FR
24372, April 8, 2024]